These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3509883

  • 1. Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants.
    Andrew ME, Coupar BE, Ada GL, Boyle DB.
    Microb Pathog; 1986 Oct; 1(5):443-52. PubMed ID: 3509883
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells.
    Bennink JR, Yewdell JW, Smith GL, Moller C, Moss B.
    Nature; 1986 Oct; 311(5986):578-9. PubMed ID: 6332992
    [Abstract] [Full Text] [Related]

  • 4. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
    Lawson CM, Bennink JR, Restifo NP, Yewdell JW, Murphy BR.
    J Virol; 1994 Jun; 68(6):3505-11. PubMed ID: 7514677
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice.
    Andrew ME, Coupar BE.
    Scand J Immunol; 1988 Jul; 28(1):81-5. PubMed ID: 2456608
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
    Wild TF, Bernard A, Spehner D, Drillien R.
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
    Blake NW, Kettle S, Law KM, Gould K, Bastin J, Townsend AR, Smith GL.
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2393-8. PubMed ID: 7561783
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
    Coupar BE, Andrew ME, Both GW, Boyle DB.
    Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin.
    Gould KG, Scotney H, Brownlee GG.
    J Virol; 1991 Oct; 65(10):5401-9. PubMed ID: 1716691
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.
    Sutter G, Wyatt LS, Foley PL, Bennink JR, Moss B.
    Vaccine; 1994 Aug; 12(11):1032-40. PubMed ID: 7975844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.